iPharmaCenter

Putting patients at center

  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon

  • Home

  • COVID-19

  • News

  • Conferences

  • Healthcare Policies & Systems

  • Regional News

    • North America
    • Europe
    • APAC

  • Patient info

  • More

    Use tab to navigate through the menu items.
    • All Posts
    • TraditionalHealthcare
    • Healthcare Systems
    • News
    • Conferences
    • Know your disease
    • COVID
    • Japan drug approvals
    • USA Pharma News | Healthcare News
    • Europe Pharma News
    • Japan drug approvals
    • Australia Pharma & Healthcare News
    • Canada Pharma and Healthcare News
    • Asia | Pharma | Healthcare News
    • Indication News
    Search
    Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief
    ipharmaservices
    • Nov 3, 2021

    Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief

    0
    Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System
    ipharmaservices
    • Mar 12, 2021

    Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System

    0
    Expected best selling pharmaceutical products (drugs) in 2021
    ipharmaservices
    • Jan 20, 2021

    Expected best selling pharmaceutical products (drugs) in 2021

    0
    ipharmaservices
    • Jan 5, 2021

    Lynparza was approved for three more indications in Japan

    0
    Merck’s Keytruda received one more indication and dosage form approval in Japan
    ipharmaservices
    • Aug 25, 2020

    Merck’s Keytruda received one more indication and dosage form approval in Japan

    0
    ipharmaservices
    • Jun 2, 2020

    Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

    0
    ipharmaservices
    • May 30, 2020

    Astellas received approval for Xtandi in Japan for prostate cancer

    0
    AstraZeneca's Lokelma approved in Japan
    ipharmaservices
    • Mar 29, 2020

    AstraZeneca's Lokelma approved in Japan

    0

    Please feel free to share your thoughts and comments. If you have questions, please comment, and we will try to get back with answers. If you liked the content, please share it on your network.

    For any further updates, contact us at ipharmaservices@gmail.com

    ©2022 by ipharmaservices